Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. 2009

Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
Department of Neurology, Iranian Center of Neurological Research, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran. ghabaeem@tums.ac.ir

Multiple sclerosis (MS) is prototype of inflammatory demyelinating disease of the central nervous system .The etiology of MS remains unclear, but according to current data the disease develops in genetically susceptible individuals and may require additional environmental triggers. The human leukocyte antigen (HLA) class II alleles (DRB1*1501, DQA1*0102, DQB1*0602) may have the strongest genetic effect in MS. In this study, the role of these alleles were investigated in 183 Iranian patients with multiple sclerosis and compared with 100 healthy individuals. HLA typing for DRB1*1501, DQA1*0102, DQB1*0602 was performed by polymerase chain reaction (PCR) amplification with sequence-specific primers (PCR-SSP) method. The results show that, HLA DR B1*1501 was significantly more frequent among MS patients (46% vs. 20%, PV = 0.0006) but DQA1*0102 haplotype was negatively associated with MS (30% vs. 50%, PV = 0.0049) and no significant association was found with DQB1*0602 and MS patients in comparison with control group (24% and 30%, PV = 0.43). No significant correlation was observed among these alleles with sex, type of disease; initial symptoms, expanded disability status scale (EDSS), as well as age at onset and familial MS. This study therefore indicates that there is no association of above HLA haplotypes with clinical presentation, disease duration, and disability in Iranian patients with MS which is in line with other previous studies in different ethnic groups.

UI MeSH Term Description Entries
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006683 HLA-DQ Antigens A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-DC Antigens,HLA-MB Antigens,HLA-DC,HLA-DQ,HLA-DS,HLA-DS Antigens,HLA-LB,HLA-LB Antigens,HLA-MB,Antigens, HLA-DC,Antigens, HLA-DQ,Antigens, HLA-DS,Antigens, HLA-LB,Antigens, HLA-MB,HLA DC Antigens,HLA DQ Antigens,HLA DS Antigens,HLA LB Antigens,HLA MB Antigens
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
January 2021, Iranian journal of child neurology,
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
September 2009, Arquivos de neuro-psiquiatria,
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
September 2009, Journal of immunology (Baltimore, Md. : 1950),
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
January 2024, Frontiers in neurology,
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
January 1993, Immunogenetics,
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
August 1997, Tissue antigens,
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
February 2008, Experimental gerontology,
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
January 2007, International review of neurobiology,
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
September 2017, International journal of reproductive biomedicine,
Mojdeh Ghabaee, and Asghar Bayati, and Shahla Amri Saroukolaei, and Mohamad Ali Sahraian, and Mohammad Hosein Sanaati, and Parisa Karimi, and Massoud Houshmand, and Homa Sadeghian, and Leila Hashemi Chelavi
August 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
Copied contents to your clipboard!